Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
This is the first weight loss treatment to target three key hormone pathways and potentially lead to greater weight loss, whilst providing additional benefits on fat metabolism and reducing the risk of fatty liver disease
Patients who prefer the privacy and convenience of telehealth combined with home delivery
As of April 2026, Wegovy is no longer on the FDA shortage list, which means compounding pharmacies can continue to prepare semaglutide only under specific conditions (patient-specific allergy to an inactive ingredient, dose not commercially available, or other medical need)
Mitsui Methylene Blue 49
US$ 20.57
US$ 28.90
US$ 29.24
US$ 21.52
US$ 23.60
